News for Abiomed, Inc. (ABMD)

We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other diversified...

Johnson & Johnson's 'AAA' rating on Credit Watch Negative at S&P following Intra-Cellular Therapies acquisition

ACTION Centers Collaborate with Johnson & Johnson MedTech to Secure FDA Labeling for Impella Support System in Pediatric Patients

The U.S. Department of Labor has announced that its Office of Federal Contract Compliance Programs and Abiomed Inc., a federal medical equipment supplier,

The S&P 500 Index is categorized into 11 sectors, and investors try to profit from the various sectors. One simple way to profit from the market is the

Earnings call: Johnson & Johnson sees growth amid challenges

The Global Cardiac Prosthetic Devices Market Size was Valued at USD 6.6 Billion in 2023 and the Worldwide Cardiac Prosthetic Devices Market Size is...

TSLA trades at a higher valuation of 6x trailing revenues, compared to 4.2x for J&J, and we think that this valuation gap will likely narrow over..

These healthcare stocks can provide enviable long-term portfolio growth.

Earnings call: Johnson & Johnson posts solid Q1 growth, eyes M&A strategy

Johnson & Johnson reportedly in talks to acquire Shockwave Medical. Potential acquisition aligns with J&J's interest in expanding into cardiovascular devices. Piper Sandler considers J&J a potential buyer due to its strong financials.

The heart pump device market continues to show a positive outlook, primarily propelled by the increasing burden of heart failure and coronary artery...

A fresh look at Johnson & Johnson is warranted, especially in light of split-off of its Consumer Health segment and amid ongoing talc litigation. Learn more on JNJ stock here.

The global ventricular assist devices (VAD) market is experiencing a surge, driven by rising heart failure rates, technological advancements, and...

The global medical device market is expected to reach USD 799.67 billion by 2030, growing at a compound annual growth rate of 5.9% throughout the forecast...

Growing incidences of organ failure is one of the significant factors influencing the Artificial Organs market growth...

Prophecy Market Insights latest research report on the Artificial Organ Market provides a comprehensive analysis of the current market scenario, growth...

[230 + Pages Research Study] According to a market research study published by The Brainy Insights, the demand analysis of congestive heart failure...

/PRNewswire/ -- The